from chatGPT:Here’s a list of some biotech companies that have issued convertible bonds, including the year and the total amount where available:
1. Moderna, Inc.
- Year Issued: 2021
- Amount: $1.34 billion
- Details: Moderna issued convertible senior notes due in 2026 to support its ongoing research and development efforts, including vaccine development.
2. Gilead Sciences, Inc.
- Year Issued: 2020
- Amount: $3.5 billion
- Details: Gilead issued convertible senior notes to strengthen its balance sheet and fund its strategic initiatives, including potential acquisitions and R&D.
3. Illumina, Inc.
- Year Issued: 2021
- Amount: $2 billion
- Details: Illumina issued convertible senior notes to finance its acquisition of Grail and support its growth strategy.
4. Biogen Inc.
- Year Issued: 2020
- Amount: $1.5 billion
- Details: Biogen issued convertible senior notes to fund its research and commercial activities.
5. Vertex Pharmaceuticals Incorporated
- Year Issued: 2019
- Amount: $1.4 billion
- Details: Vertex issued convertible senior notes to support its ongoing research and development programs.
6. Sarepta Therapeutics, Inc.
- Year Issued: 2017
- Amount: $750 million
- Details: Sarepta issued convertible senior notes to finance its gene therapy initiatives and other research programs.
7. Neurocrine Biosciences, Inc.
- Year Issued: 2022
- Amount: $500 million
- Details: Neurocrine issued convertible senior notes to support its R&D and operational needs.
8. NantKwest, Inc.
- Year Issued: 2021
- Amount: $200 million
- Details: NantKwest issued convertible senior notes to fund its clinical trials and product development.
- Forums
- ASX - By Stock
- Ann: Telix Successfully Prices A$650M Convertible Bonds
from chatGPT:Here’s a list of some biotech companies that have...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.48 |
Change
0.030(0.15%) |
Mkt cap ! $6.854B |
Open | High | Low | Value | Volume |
$20.35 | $20.83 | $20.30 | $10.68M | 520.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1586 | $20.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.58 | 898 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 387 | 20.410 |
1 | 196 | 20.400 |
1 | 2 | 20.300 |
1 | 1000 | 20.290 |
1 | 300 | 20.160 |
Price($) | Vol. | No. |
---|---|---|
20.700 | 4500 | 1 |
20.750 | 500 | 1 |
20.800 | 1792 | 2 |
20.880 | 1784 | 2 |
20.890 | 3000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |